Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action
The Journal of Clinical Psychiatry · 26.04.2017 · 78 (04) · e415-e419
DOI: 10.4088/jcp.17f11567 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Psychiatry, erschienen am 26.04.2017. Verfasst von Chittaranjan Andrade. Beteiligte Einrichtung: Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com. Die Arbeit wurde bisher 79-mal zitiert (Crossref).
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com.
Zitieren
APA
Andrade, C. (2017). Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action. The Journal of Clinical Psychiatry, 78(04), e415-e419. https://doi.org/10.4088/jcp.17f11567
Vancouver
Andrade C. Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action. The Journal of Clinical Psychiatry. 2017;78(04):e415-e419. doi:10.4088/jcp.17f11567
BibTeX
@article{Andrade2017,
author = {Andrade, Chittaranjan},
title = {Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action},
journal = {The Journal of Clinical Psychiatry},
year = {2017},
volume = {78},
number = {04},
pages = {e415--e419},
doi = {10.4088/jcp.17f11567}
}
EUVIMED